Abstract
Although numerous reports have appeared in the literature over the past 100 years describing various antiepileptic drugs, it is not possible to justify preference for a particular drug to treat specific types of adult seizures. Since the introduction of bromides a century ago, numerous antiepileptic drugs have been developed. Four such drugs, carbamazepine, phenobarbital, phenytoin, and primidone, have been found to be effective and acceptably safe for management of partial and secondarily generalized seizures. However, no studies have demonstrated the superior efficacy of any one drug. Clinical selection of therapy often is based on expected or assumed risk or absence of specific side effects. This review of classic papers demonstrates inconclusive and conflicting information. A new approach to the comparative evaluation of the efficacy and toxicity of major antiepileptic drugs is needed.
- © 1983 by the American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
